As the investigative site landscape becomes increasingly segmented, are traditional approaches to site selection and study execution still delivering the best results? Growing operational complexity, changing ownership models, new technologies and increasing expectations for patient-centric trials are creating meaningful differences among academic medical center-affiliated sites, independent community-based sites and larger site networks, with important implications for patient access and trial performance.
Drawing on insights from the Tufts Center for the Study of Drug Development (Tufts CSDD) global research study, “Mapping and Assessing the Global Investigative Site Landscape: Different Site Execution Models,” this fireside discussion brings together perspectives spanning research, biotech, a site network and a CRO to examine the evolving investigative site landscape and what it means for clinical trial strategy and execution.
Panelists will explore how sponsors can balance therapeutic expertise, demonstrated performance, infrastructure, patient access and established relationships when selecting sites, and whether reliance on familiar partners may limit opportunities to identify emerging high-performing sites and alternative execution models.
The conversation will also address patient access and decentralized clinical trial approaches, including whether new technologies are truly reducing participation barriers or simply shifting operational burden to sites. The featured speakers will consider how sponsors, CROs and sites can maintain accountability for the patient experience while adapting execution models to different site capabilities.
Finally, speakers will explore the role of data-driven site selection, communication, financial sustainability and cross-industry collaboration in building more flexible study strategies that improve trial performance while supporting sites and patients.
Register for this webinar to learn how patient access can be strengthened through more effective site selection, decentralized trial approaches and flexible clinical trial execution models.
Speakers
Joan A. Chambers, Senior Consultant, Tufts Center for the Study of Drug Development
With more than 30 years of experience in the health and life sciences industry, Joan has held executive leadership roles across multiple organizations. She brings extensive expertise in strategic planning, integrated marketing, communications, educational initiatives, team leadership and business development for both B2B and B2C audiences. She is passionate about fostering meaningful partnerships, enhancing audience engagement and driving scalable and sustainable growth.
Joan is a Senior Consultant at the Tufts Center for the Study of Drug Development (Tufts CSDD), where she provides strategic guidance on special projects and the organization’s membership program. She serves on the PharmaTimes Executive Steering Committee for CROY-Americas and contributes to the CTTI Project Watchtower initiative. She is also a Program Committee Member for the DIA 2025–2027 Global Annual Meeting, an Advisor for CHI’s SCOPE 2026 Site Engagement & Enablement track and an Advisory Board member for the Pharmaceutical Business Conference Group and One Rare.
Read more...
Previously, Joan served as a Judge for the Citeline Awards, a Board Member at BioBridges, a member of the Greater Gift Board of Directors for nine years and a CISCRP Advisory Board member for more than a decade. Her executive leadership experience includes serving as CEO of Greater Gift and COO of CenterWatch, along with leadership roles at CISCRP, ClinX, SCORR Marketing, CHI, Tufts CSDD and PAREXEL. An active member of the Drug Information Association (DIA), Joan has published articles in leading clinical research trade journals and is a frequent speaker at industry conferences.
Read Less...
Phill Gallacher, Senior Vice President, Head of Clinical Operations & Program Management, Cullinan Therapeutics, Inc.
Phill Gallacher is a biopharmaceutical executive with more than 25 years of global experience leading clinical development operations, program management and cross-functional drug development teams across biotechnology, pharmaceutical, CRO and medical device organizations. He currently serves as Senior Vice President and Head of Clinical Operations & Program Management at Cullinan Therapeutics, where he provides strategic leadership for the execution of the company’s clinical development portfolio spanning immunology and hematology programs.
Throughout his career, Phill has built a reputation for operational excellence, organizational leadership and the successful advancement of complex clinical development programs from early research through late-stage development.
Message Presenter
Chloe Rose, PhD, Vice President, Site Solutions & Portfolio Management, Pratia
Chloe Rose joined Pratia in 2021 as Global Portfolio Lead and is now the Vice President of Site Solutions. She oversees Global Feasibility & Proposals, Budget & Contract Negotiations, the outsourcing of clinical research coordinators and data managers and Global Client Relationship Management. Previously, she worked at a global pharmaceutical company as a European and then Global Clinical Trial Manager, where she led strategic operations and supported business acquisitions to enhance efficiency. Chloe is passionate about accelerating access to innovative treatments for patients. She holds a PhD in Bioengineering and a BSc in Pharmacology from the University of Southampton, UK.
Message Presenter
Almenia Garvey, MSc, Executive Director, Global Feasibility, Site & Patient Engagement, Allucent
Almenia Garvey brings over 25 years of expertise in Site and Investigator Relations, with a proven track record of driving global strategies that enhance clinical trial execution. She has also led and contributed to initiatives advancing diversity and inclusion in clinical trials, with a focus on improving access, representation and patient-centric approaches across global study populations.
In her current role as Sr. Director, Global Feasibility, Site and Patient Engagement at Allucent, Almenia leads the organization’s global site and patient engagement strategy, building robust site intelligence to optimize site identification and accelerate study start-up and delivery.
Almenia holds a Master of Science degree from Ulster University, N. Ireland and a Bachelor’s degree from the University of North Carolina at Chapel Hill. In addition, Almenia is an EMCC-accredited Coach Practitioner and actively contributes to the community by serving on the Board of Directors for two charities: Nvolve and Brandon’s Baggies.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Clinical Operations and Site Management leaders
- Clinical Trial/Project Management and Oversight teams
- Patient Engagement, Recruitment and Retention leaders
- Biopharma Program and Portfolio leaders
- Chief Medical Officers and Clinical Development leaders involved in study design
What You Will Learn
In this webinar, attendees will gain insights on:
- Using site segmentation to strengthen feasibility and study execution
- Balancing trusted site relationships with performance potential, site capabilities and patient access
- When decentralized technologies reduce or shift trial burden
- Strengthening sponsor-CRO-site alignment to improve trial performance and patient experience
Xtalks Partner
Allucent
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including clinical trial operations, regulatory strategy, clinical pharmacology, pharmacovigilance, and biostatistical programming consulting. With more than 30 years of experience in over 70 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account